Barclays Maintains Equal-Weight on Exelixis, Raises Price Target to $54
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Barclays analyst Etzer Darout maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $49 to $54.
Barclays analyst Etzer Darout maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $49 to $54.